Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1332350
                    [Title] => Reaction to allopurinol are few, but severe
                    [Summary] => 
Severe cutaneous adverse actions requiring hospitalization occurred in 45 of 90,358 patients who began allopurinol treatment within a specified time period, for an incidence rate of 0.69 per 1,000 person years.

                    [DatePublished] => 2014-06-08 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 617159
                    [Title] => New agents for gout provide alternatives to allopurinol
                    [Summary] => 
The likely approval of febuxostat for the treatment of gout means that there soon will be an alternative for the underserved group of patients with severe disease who cannot tolerate allopurinol.
                    [DatePublished] => 2010-10-03 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 446062
                    [Title] => Drug tainted with fungus in Hong Kong
                    [Summary] => 
HONG KONG (AP) - Hong Kong health authorities have ordered a local drug-maker to suspend production after its medicine that treats gout was found tainted with fungus, officials said today.
                    [DatePublished] => 2009-03-07 19:31:43
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => 
                )

        )

)

ALLOPURINOL

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1332350
                    [Title] => Reaction to allopurinol are few, but severe
                    [Summary] => 
Severe cutaneous adverse actions requiring hospitalization occurred in 45 of 90,358 patients who began allopurinol treatment within a specified time period, for an incidence rate of 0.69 per 1,000 person years.

                    [DatePublished] => 2014-06-08 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 617159
                    [Title] => New agents for gout provide alternatives to allopurinol
                    [Summary] => 
The likely approval of febuxostat for the treatment of gout means that there soon will be an alternative for the underserved group of patients with severe disease who cannot tolerate allopurinol.
                    [DatePublished] => 2010-10-03 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 446062
                    [Title] => Drug tainted with fungus in Hong Kong
                    [Summary] => 
HONG KONG (AP) - Hong Kong health authorities have ordered a local drug-maker to suspend production after its medicine that treats gout was found tainted with fungus, officials said today.
                    [DatePublished] => 2009-03-07 19:31:43
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => 
                    [SectionUrl] => 
                    [URL] => 
                )

        )

)

abtest

Reaction to allopurinol are few, but severe

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | June 8, 2014 - 12:00am

Severe cutaneous adverse actions requiring hospitalization occurred in 45 of 90,358 patients who began allopurinol treatment within a specified time period, for an incidence rate of 0.69 per 1,000 person years....

Opinion

New agents for gout provide alternatives to allopurinol

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | October 3, 2010 - 12:00am

The likely approval of febuxostat for the treatment of gout means that there soon will be an alternative for the underserved group of patients with severe disease who cannot tolerate allopurinol.

Opinion

Drug tainted with fungus in Hong Kong

March 7, 2009 - 7:31pm

HONG KONG (AP) - Hong Kong health authorities have ordered a local drug-maker to suspend production after its medicine that treats gout was found tainted with fungus, officials said today.